The Research Triangle is a region in central North Carolina anchored by three cities, Raleigh, Durham, and Chapel Hill, and defined by the three major research universities located there: Duke University, the University of North Carolina at Chapel Hill, and North Carolina State University. The name comes from the roughly triangular shape these institutions form on a map, and the region has grown into one of the most concentrated hubs of scientific research, technology, and biotech in the United States.
The Three Universities at the Core
Each university brings a different academic strength to the region. UNC-Chapel Hill is the flagship public university in the state and ranks ninth nationally for research, with annual research spending topping $1.55 billion. Duke University, a private institution in Durham, is one of the top-funded medical research centers in the country. NC State, located in Raleigh, is a land-grant university with deep strengths in engineering, agriculture, and applied sciences.
Together, these three schools produce a steady pipeline of graduates, patents, and startup companies that feed the local economy. The proximity of a major public research university, a private research powerhouse, and a large engineering-focused school within a 30-mile stretch is unusual, and it’s the main reason the region developed the way it did.
Research Triangle Park
People sometimes confuse the Research Triangle (the broader region) with Research Triangle Park, or RTP. The Park is a specific 7,000-acre planned research campus located between Raleigh and Durham, founded in 1959 to attract companies that could benefit from the nearby universities. It was one of the first research parks in the country, and for decades it served as the region’s economic engine, housing large campuses for companies in pharmaceuticals, computing, and telecommunications.
RTP still operates today and hosts hundreds of companies, but the broader Triangle economy has long since expanded beyond the Park’s borders. Tech firms, biotech startups, and corporate offices now spread across Raleigh, Durham, Chapel Hill, and surrounding towns like Cary, Morrisville, and Apex.
A National Life Sciences Hub
The Triangle has become one of the top biopharma clusters in the country. Real estate firm JLL has named Raleigh-Durham the nation’s top biomanufacturing hub, citing the region’s history of large-scale drug production, its concentration of skilled workers, and the steady flow of research from university spinouts. North Carolina ranks fifth nationally in funding from the National Institutes of Health, pulling in $3.328 billion across more than 4,200 awards. The state has over 75,000 biotech jobs and 18.2 million square feet of lab space, with that number still growing.
Venture capital follows this activity. North Carolina biotech companies received $533 million in venture funding in 2023, with another $261 million flowing in during just the first half of 2024. The combination of university research, available lab space, and a workforce trained locally makes the Triangle particularly attractive for companies looking to take a drug from early research through manufacturing.
The Broader Tech Economy
Life sciences get the most attention, but the Triangle’s economy is far more diverse. The region is a growing center for software engineering, artificial intelligence, and machine learning. Apple announced plans to build a new campus and engineering hub in Research Triangle Park, investing more than $1 billion and creating at least 3,000 jobs in AI, machine learning, and software engineering. That followed similar expansions from other major tech companies drawn by the talent pool and lower cost of living compared to Silicon Valley or the Boston corridor.
The economic growth numbers reflect this momentum. A model from the Kenan Institute at UNC ranked the Raleigh-Durham metro area fourth in the country for GDP growth among the 150 most populous metro areas. That kind of ranking puts the Triangle alongside much larger cities like Austin and Nashville that have seen explosive growth in recent years.
What Makes the Region Different
Plenty of American cities have a good university nearby. What sets the Triangle apart is the density of research institutions relative to the size of the metro area, combined with decades of deliberate investment in making it easy for companies to locate near those institutions. The creation of RTP in the late 1950s was an early, intentional bet that proximity to university research would attract private industry, and it paid off over generations.
The cost of living, while rising, remains lower than competing research hubs like San Francisco, Boston, or San Diego. North Carolina’s relatively business-friendly regulatory environment also plays a role. For companies weighing where to build a lab, hire scientists, or manufacture drugs, the Triangle offers university partnerships, an existing talent base, and room to grow, all in the same region.
The population of the Raleigh-Durham metro area has grown rapidly in the past two decades, and the region now functions as a single interconnected economy rather than three separate college towns. If you’re reading about a biotech breakthrough, a tech company expansion, or a university research milestone coming out of central North Carolina, it’s almost certainly happening somewhere within this triangle.